Security & Protection Services
Compare Stocks
5 / 10Stock Comparison
REZI vs JCI vs HON vs CARR vs ALLE
Revenue, margins, valuation, and 5-year total return — side by side.
Construction
Conglomerates
Construction
Security & Protection Services
REZI vs JCI vs HON vs CARR vs ALLE — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | |||||
|---|---|---|---|---|---|
| Industry | Security & Protection Services | Construction | Conglomerates | Construction | Security & Protection Services |
| Market Cap | $6.04B | $85.23B | $136.91B | $56.07B | $11.76B |
| Revenue (TTM) | $7.47B | $24.43B | $36.76B | $21.87B | $4.16B |
| Net Income (TTM) | $-527M | $3.53B | $4.10B | $1.32B | $634M |
| Gross Margin | 29.4% | 36.6% | 36.9% | 24.8% | 45.0% |
| Operating Margin | 8.1% | 13.6% | 14.9% | 8.1% | 20.6% |
| Forward P/E | 13.1x | 29.4x | 20.5x | 24.2x | 15.6x |
| Total Debt | $3.17B | $11.19B | $34.58B | $12.67B | $2.28B |
| Cash & Equiv. | $661M | $379M | $12.49B | $1.55B | $356M |
REZI vs JCI vs HON vs CARR vs ALLE — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
| Stock | May 20 | May 26 | Return |
|---|---|---|---|
| Resideo Technologie… (REZI) | 100 | 570.4 | +470.4% |
| Johnson Controls In… (JCI) | 100 | 443.3 | +343.3% |
| Honeywell Internati… (HON) | 100 | 148.1 | +48.1% |
| Carrier Global Corp… (CARR) | 100 | 327.8 | +227.8% |
| Allegion plc (ALLE) | 100 | 137.2 | +37.2% |
Price return only. Dividends and distributions are not included.
Quick Verdict: REZI vs JCI vs HON vs CARR vs ALLE
Each card shows where this stock fits in a portfolio — not just who wins on paper.
REZI is the #2 pick in this set and the best alternative if growth and momentum is your priority.
- 10.5% revenue growth vs CARR's -3.3%
- +111.6% vs CARR's -2.8%
JCI lags the leaders in this set but could rank higher in a more targeted comparison.
HON ranks third and is worth considering specifically for income & stability.
- Dividend streak 15 yrs, beta 0.74, yield 2.1%
- 2.1% yield, 15-year raise streak, vs CARR's 1.4%
CARR is the clearest fit if your priority is long-term compounding.
- 493.6% 10Y total return vs JCI's 343.3%
ALLE carries the broadest edge in this set and is the clearest fit for growth exposure and sleep-well-at-night.
- Rev growth 7.8%, EPS growth 9.1%, 3Y rev CAGR 7.5%
- Lower volatility, beta 0.67, current ratio 1.84x
- PEG 0.92 vs HON's 11.18
- Beta 0.67, yield 1.5%, current ratio 1.84x
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | 10.5% revenue growth vs CARR's -3.3% | |
| Value | Lower P/E (15.6x vs 24.2x) | |
| Quality / Margins | 15.2% margin vs REZI's -7.1% | |
| Stability / Safety | Beta 0.67 vs REZI's 2.27 | |
| Dividends | 2.1% yield, 15-year raise streak, vs CARR's 1.4% | |
| Momentum (1Y) | +111.6% vs CARR's -2.8% | |
| Efficiency (ROA) | 12.3% ROA vs REZI's -6.2%, ROIC 18.1% vs 9.0% |
REZI vs JCI vs HON vs CARR vs ALLE — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
REZI vs JCI vs HON vs CARR vs ALLE — Financial Metrics
Side-by-side numbers across 5 stocks — who leads on profitability, valuation, growth, and risk.
Who Leads Where
ALLE leads in 2 of 6 categories
REZI leads 2 • HON leads 1 • JCI leads 0 • CARR leads 0 • 1 tied
Explore the data ↓Income & Cash Flow (Last 12 Months)
ALLE leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
HON is the larger business by revenue, generating $36.8B annually — 8.8x ALLE's $4.2B. ALLE is the more profitable business, keeping 15.2% of every revenue dollar as net income compared to REZI's -7.1%. On growth, ALLE holds the edge at +9.7% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | |||||
|---|---|---|---|---|---|
| RevenueTrailing 12 months | $7.5B | $24.4B | $36.8B | $21.9B | $4.2B |
| EBITDAEarnings before interest/tax | $802M | $3.9B | $6.5B | $3.1B | $959M |
| Net IncomeAfter-tax profit | -$527M | $3.5B | $4.1B | $1.3B | $634M |
| Free Cash FlowCash after capex | -$1.3B | $1.4B | $4.2B | $1.7B | $704M |
| Gross MarginGross profit ÷ Revenue | +29.4% | +36.6% | +36.9% | +24.8% | +45.0% |
| Operating MarginEBIT ÷ Revenue | +8.1% | +13.6% | +14.9% | +8.1% | +20.6% |
| Net MarginNet income ÷ Revenue | -7.1% | +14.5% | +11.2% | +6.0% | +15.2% |
| FCF MarginFCF ÷ Revenue | -16.8% | +5.7% | +11.4% | +7.6% | +16.9% |
| Rev. Growth (YoY)Latest quarter vs prior year | +2.0% | +8.2% | -6.9% | +2.4% | +9.7% |
| EPS Growth (YoY)Latest quarter vs prior year | +11.4% | +38.9% | -41.9% | -40.4% | -7.0% |
Valuation Metrics
REZI leads this category, winning 5 of 7 comparable metrics.
Valuation Metrics
At 18.4x trailing earnings, ALLE trades at a 65% valuation discount to JCI's 52.9x P/E. Adjusting for growth (PEG ratio), ALLE offers better value at 1.08x vs HON's 15.99x — a lower PEG means you pay less per unit of expected earnings growth.
| Metric | |||||
|---|---|---|---|---|---|
| Market CapShares × price | $6.0B | $85.2B | $136.9B | $56.1B | $11.8B |
| Enterprise ValueMkt cap + debt − cash | $8.5B | $96.0B | $159.0B | $67.2B | $13.7B |
| Trailing P/EPrice ÷ TTM EPS | -10.68x | 52.95x | 29.36x | 39.48x | 18.39x |
| Forward P/EPrice ÷ next-FY EPS est. | 13.07x | 29.38x | 20.52x | 24.18x | 15.60x |
| PEG RatioP/E ÷ EPS growth rate | — | 2.06x | 15.99x | — | 1.08x |
| EV / EBITDAEnterprise value multiple | 10.65x | 26.01x | 19.99x | 21.71x | 13.83x |
| Price / SalesMarket cap ÷ Revenue | 0.81x | 3.61x | 3.66x | 2.58x | 2.89x |
| Price / BookPrice ÷ Book value/share | 2.06x | 7.03x | 9.00x | 4.02x | 5.72x |
| Price / FCFMarket cap ÷ FCF | — | 88.32x | 25.39x | 33.04x | 17.14x |
Profitability & Efficiency
ALLE leads this category, winning 7 of 9 comparable metrics.
Profitability & Efficiency
ALLE delivers a 32.1% return on equity — every $100 of shareholder capital generates $32 in annual profit, vs $-18 for REZI. JCI carries lower financial leverage with a 0.86x debt-to-equity ratio, signaling a more conservative balance sheet compared to HON's 2.24x. On the Piotroski fundamental quality scale (0–9), JCI scores 6/9 vs CARR's 4/9, reflecting solid financial health.
| Metric | |||||
|---|---|---|---|---|---|
| ROE (TTM)Return on equity | -18.1% | +24.9% | +23.1% | +9.1% | +32.1% |
| ROA (TTM)Return on assets | -6.2% | +9.0% | +5.3% | +3.5% | +12.3% |
| ROICReturn on invested capital | +9.0% | +8.5% | +12.6% | +6.7% | +18.1% |
| ROCEReturn on capital employed | +9.3% | +9.8% | +12.6% | +7.2% | +20.8% |
| Piotroski ScoreFundamental quality 0–9 | 4 | 6 | 6 | 4 | 6 |
| Debt / EquityFinancial leverage | 1.09x | 0.86x | 2.24x | 0.90x | 1.10x |
| Net DebtTotal debt minus cash | $2.5B | $10.8B | $22.1B | $11.1B | $1.9B |
| Cash & Equiv.Liquid assets | $661M | $379M | $12.5B | $1.6B | $356M |
| Total DebtShort + long-term debt | $3.2B | $11.2B | $34.6B | $12.7B | $2.3B |
| Interest CoverageEBIT ÷ Interest expense | -2.36x | 18.41x | 3.92x | 5.76x | 8.61x |
Total Returns (Dividends Reinvested)
REZI leads this category, winning 3 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in JCI five years ago would be worth $22,286 today (with dividends reinvested), compared to $10,324 for ALLE. Over the past 12 months, REZI leads with a +111.6% total return vs CARR's -2.8%. The 3-year compound annual growth rate (CAGR) favors REZI at 34.9% vs HON's 5.1% — a key indicator of consistent wealth creation.
| Metric | |||||
|---|---|---|---|---|---|
| YTD ReturnYear-to-date | +14.5% | +14.2% | +10.9% | +26.3% | -14.6% |
| 1-Year ReturnPast 12 months | +111.6% | +56.9% | +2.8% | -2.8% | -1.0% |
| 3-Year ReturnCumulative with dividends | +145.5% | +127.9% | +16.2% | +63.4% | +32.6% |
| 5-Year ReturnCumulative with dividends | +33.0% | +122.9% | +3.3% | +58.0% | +3.2% |
| 10-Year ReturnCumulative with dividends | +38.9% | +343.3% | +135.1% | +493.6% | +127.3% |
| CAGR (3Y)Annualised 3-year return | +34.9% | +31.6% | +5.1% | +17.8% | +9.9% |
Risk & Volatility
Evenly matched — JCI and ALLE each lead in 1 of 2 comparable metrics.
Risk & Volatility
ALLE is the less volatile stock with a 0.67 beta — it tends to amplify market swings less than REZI's 2.27 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. JCI currently trades 94.5% from its 52-week high vs ALLE's 74.7% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | |||||
|---|---|---|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 2.27x | 0.97x | 0.74x | 1.19x | 0.67x |
| 52-Week HighHighest price in past year | $45.29 | $147.32 | $248.18 | $81.09 | $183.11 |
| 52-Week LowLowest price in past year | $18.88 | $87.77 | $186.76 | $50.24 | $131.25 |
| % of 52W HighCurrent price vs 52-week peak | +88.9% | +94.5% | +87.1% | +82.8% | +74.7% |
| RSI (14)Momentum oscillator 0–100 | 61.4 | 56.2 | 45.1 | 64.2 | 38.5 |
| Avg Volume (50D)Average daily shares traded | 1.1M | 3.3M | 3.7M | 6.6M | 887K |
Analyst Outlook
HON leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
Analyst consensus: REZI as "Buy", JCI as "Buy", HON as "Buy", CARR as "Buy", ALLE as "Hold". Consensus price targets imply 26.1% upside for ALLE (target: $173) vs -0.9% for JCI (target: $138). For income investors, HON offers the higher dividend yield at 2.14% vs REZI's 0.58%.
| Metric | |||||
|---|---|---|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy | Buy | Buy | Hold |
| Price TargetConsensus 12-month target | $40.00 | $138.00 | $243.83 | $67.50 | $172.50 |
| # AnalystsCovering analysts | 7 | 45 | 28 | 26 | 23 |
| Dividend YieldAnnual dividend ÷ price | +0.6% | +1.1% | +2.1% | +1.4% | +1.5% |
| Dividend StreakConsecutive years of raises | 2 | 5 | 15 | 6 | 12 |
| Dividend / ShareAnnual DPS | $0.23 | $1.49 | $4.63 | $0.91 | $2.03 |
| Buyback YieldShare repurchases ÷ mkt cap | 0.0% | +7.0% | +2.8% | +5.2% | +0.7% |
ALLE leads in 2 of 6 categories (Income & Cash Flow, Profitability & Efficiency). REZI leads in 2 (Valuation Metrics, Total Returns). 1 tied.
REZI vs JCI vs HON vs CARR vs ALLE: Key Questions Answered
10 questions · data-driven answers · updated daily
01Is REZI or JCI or HON or CARR or ALLE a better buy right now?
For growth investors, Resideo Technologies, Inc.
(REZI) is the stronger pick with 10. 5% revenue growth year-over-year, versus -3. 3% for Carrier Global Corporation (CARR). Allegion plc (ALLE) offers the better valuation at 18. 4x trailing P/E (15. 6x forward), making it the more compelling value choice. Analysts rate Resideo Technologies, Inc. (REZI) a "Buy" — based on 7 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — REZI or JCI or HON or CARR or ALLE?
On trailing P/E, Allegion plc (ALLE) is the cheapest at 18.
4x versus Johnson Controls International plc at 52. 9x. On forward P/E, Resideo Technologies, Inc. is actually cheaper at 13. 1x — notably different from the trailing picture, reflecting expected earnings growth. The PEG ratio (P/E divided by earnings growth rate) is the most growth-adjusted single valuation metric: Allegion plc wins at 0. 92x versus Honeywell International Inc. 's 11. 18x — a PEG below 1. 0 traditionally signals the market is underpricing earnings growth.
03Which is the better long-term investment — REZI or JCI or HON or CARR or ALLE?
Over the past 5 years, Johnson Controls International plc (JCI) delivered a total return of +122.
9%, compared to +3. 2% for Allegion plc (ALLE). Over 10 years, the gap is even starker: CARR returned +493. 6% versus REZI's +38. 9%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — REZI or JCI or HON or CARR or ALLE?
By beta (market sensitivity over 5 years), Allegion plc (ALLE) is the lower-risk stock at 0.
67β versus Resideo Technologies, Inc. 's 2. 27β — meaning REZI is approximately 242% more volatile than ALLE relative to the S&P 500. On balance sheet safety, Johnson Controls International plc (JCI) carries a lower debt/equity ratio of 86% versus 2% for Honeywell International Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — REZI or JCI or HON or CARR or ALLE?
By revenue growth (latest reported year), Resideo Technologies, Inc.
(REZI) is pulling ahead at 10. 5% versus -3. 3% for Carrier Global Corporation (CARR). On earnings-per-share growth, the picture is similar: Allegion plc grew EPS 9. 1% year-over-year, compared to -718. 0% for Resideo Technologies, Inc.. Over a 3-year CAGR, CARR leads at 7. 9% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — REZI or JCI or HON or CARR or ALLE?
Allegion plc (ALLE) is the more profitable company, earning 15.
8% net margin versus -7. 1% for Resideo Technologies, Inc. — meaning it keeps 15. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: ALLE leads at 21. 1% versus 8. 1% for REZI. At the gross margin level — before operating expenses — ALLE leads at 45. 2%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is REZI or JCI or HON or CARR or ALLE more undervalued right now?
The PEG ratio (forward P/E divided by expected earnings growth rate) is the most precise measure of undervaluation relative to growth potential.
By this metric, Allegion plc (ALLE) is the more undervalued stock at a PEG of 0. 92x versus Honeywell International Inc. 's 11. 18x. A PEG below 1. 0 is traditionally considered the threshold for growth-adjusted undervaluation. On forward earnings alone, Resideo Technologies, Inc. (REZI) trades at 13. 1x forward P/E versus 29. 4x for Johnson Controls International plc — 16. 3x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for ALLE: 26. 1% to $172. 50.
08Which pays a better dividend — REZI or JCI or HON or CARR or ALLE?
All stocks in this comparison pay dividends.
Honeywell International Inc. (HON) offers the highest yield at 2. 1%, versus 0. 6% for Resideo Technologies, Inc. (REZI).
09Is REZI or JCI or HON or CARR or ALLE better for a retirement portfolio?
For long-horizon retirement investors, Allegion plc (ALLE) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.
67), 1. 5% yield, +127. 3% 10Y return). Resideo Technologies, Inc. (REZI) carries a higher beta of 2. 27 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (ALLE: +127. 3%, REZI: +38. 9%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between REZI and JCI and HON and CARR and ALLE?
Both stocks operate in the Industrials sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform all of them.
You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.